Largest Biotechnology companies in United States by Market Capitalization

This ranking features the largest 525 Biotechnology companies in United States ranked by Market Capitalization, totaling a Market Capitalization of USD 2.83 T, for July 09, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

…

Frequently Asked Questions

Which Biotechnology company in United States has the highest Market Capitalization ?

The Biotechnology company in United States with the highest Market Capitalization is AbbVie Inc. (NYSE: ABBV) at USD 335.21 B.

Which Biotechnology company in United States has the lowest Market Capitalization ?

The Biotechnology company in United States with the lowest Market Capitalization is EyeGate Pharmaceuticals, Inc. (NasdaqGM: EYEG) at None.

What are the top 10 Biotechnology companies in United States by Market Capitalization ?

The top 10 Biotechnology companies in United States by Market Capitalization are AbbVie Inc., Abbott Laboratories, Merck & Co., Inc., Thermo Fisher Scientific Inc., Amgen Inc., Boston Scientific Corporation, Pfizer Inc., Danaher Corporation, Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated.

What are the bottom 10 Biotechnology companies in United States by Market Capitalization ?

The bottom 10 Biotechnology companies in United States by Market Capitalization are EyeGate Pharmaceuticals, Inc., Shuttle Pharmaceuticals Holdings, Inc., 22nd Century Group, Inc., Alzamend Neuro, Inc., Longevity Health Holdings Inc., Bluejay Diagnostics, Inc., Onconetix, Inc., iSpecimen Inc., Applied DNA Sciences, Inc. and Protagenic Therapeutics, Inc..